Multicare Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- The Best Places to Work organization announced today the list of the top 17 Best Places to Work in Asia Pacific for 2022. Topping this year's ranking was Amway, a multi-level marketing company that sells health, beauty, and home care products followed by Novo Nordisk, the leading global healthcare company. Alconsecured the third position among the top 17 most performing organizations across the region. To be considered, companies must be identified as outstanding employers at least in one of the countries across the region. For the past couple of ye...

SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- The Best Places to Work organization announced today the list of the top 17 Best Places to Work in Asia Pacific for 2022. Topping this year's ranking was Amway, a multi-level marketing company that sells health, beauty, and home care products followed by Novo Nordisk, the leading global healthcare company. Alcon secured the...

According to the agreement, Lupin's subsidiary in the Philippines, Multicare Pharmaceuticals, would seek marketing clearance and will be responsible for the biosimilars' distribution and commercialization if authorized.

This agreement enhances Multicare's oncology, rheumatology, gastroenterology, and ophthalmology, portfolio, which currently consists of three biosimilar candidates and over 50 generic medicines.

Uniindia: Mumbai, Sep 7 (UNI) Pharma major Lupin on Wednesday said it has signed an exclusive license and supply agreement to commercialize five of Alvotech’s proposed biosimilars in the Philippines with DKSH, a leading partner for healthcare companies<br /